Medical Foods


Provide an understanding of the medical foods market, including the process to get approval for medical foods, and case studies of companies that have created medical food products

Early Findings

The market size of the global medical foods market is projected to hit $27.2 billion by 2025, with an estimated CAGR of 6.7%.

Key factors driving growth in medical foods include an increase in the geriatric population and increase in chronic diseases in the general population.

The disease most associated with medical food growth is diabetes, with food related to chronic kidney disorder also expected to contribute to significant growth in the coming years.

Key companies in the medical food space include Danone S.A., Nestle S.A., Abbott Laboratories, Fresenius Kabi, and Mead Johnsons & Company, LLC.

Hormel Foods introduced their medical food line in 2016, Hormel Vital Cuisine, which was designed to meet the nutritional needs of cancer patients.

Abbott Nutrition has a range of medical food lines, related to various medical conditions and age groups, including EleCare, Glucerna, Hi-Cal, Jevity, Juven, and Promod.
Nestle’s medical foods are sold under Nestlé Health Science brands, which include Alfaré Althera Alfamino, Meritene, Boost, Modulen, Impact, Isosource, Optisource, Novasource, and Optifast.

It is also noted that not all foods that are used for dietary management related to a disease are medical foods, rather that foods that are considered to fall in the medical food space are specially formulated and processed to be used for the dietary management of a disease.

Medical foods in the US are regulated by the U.S. Food and Drug Administration under the Food Drug and Cosmetic Act (Regulations 21 CFR 101.9).

Proposed next steps:

You need to be the project owner to select a next step.